![]() Inotrem Inotrem is a biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a focus on critical care. | ![]() Accure Therapeutics Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. | ![]() JSK Therapeutics JSK Therapeutics is a biotechnology company that engages in developing new anti-cancer therapeutics. | ||
Founding Date | Founding Date 2020 | Founding Date 2013 | Founding Date 2020 | Founding Date N/A |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Cambridge, US HQ Boston, US | Locations Paris, FR HQ Paris, FR Vandœuvre Lès Nancy, FR | Locations Barcelona, ES HQ | Locations Salt Lake City, US HQ |
Employees | Employees 67 | Employees N/A | Employees N/A | Employees N/A |
Funding | ||||
Latest funding round | Latest funding round $ 150m (about 4 years ago) | Latest funding round $ 5.5m (over 6 years ago) | Latest funding round $ 8.3m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 236m | Total funding raised $ 71.6m | Total funding raised $ 8.3m | Total funding raised N/A |

Inotrem is a biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a focus on critical care.
View company
Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy.
View company
JSK Therapeutics is a biotechnology company that engages in developing new anti-cancer therapeutics.
View company